Key Market Indicators
**American Vaccination Coverage to Remain Stagnant at 93% for Young Children by 2028** The vaccination coverage for American children aged one year old is projected to hold steady at 93% by 2028, reflecting no change from the current rate in 2023. This static trend has been observed since 1985, indicating a long-term plateau in the country's vaccination rates for this age group. **Vaccine Exports to See Modest Growth** In contrast, the American vaccine export market is expected to experience modest growth over the next five years. By 2028, vaccine exports are forecasted to reach approximately $2.5 billion, up from $2.3 billion in 2023. This represents a compound annual growth rate (CAGR) of 1%. Despite this growth, the overall supply of vaccines from the U.S. has decreased by 0.6% annually since 1996. **Rising Vaccine Imports Reflect Increasing Demand** On the import side, the U.S. is set to see a significant increase in vaccine imports. By 2028, vaccine imports are anticipated to hit roughly $8.5 billion, rising from $7 billion in 2023. This growth represents an average annual increase of 2.9%. Since 1996, the demand for imported vaccines in the U.S. has surged by 4.1% each year, highlighting a growing reliance on foreign vaccine supplies.
